THE POTENTIAL OF BACTERIOPHAGE THERAPY AS AN ALTERNATIVE TREATMENT FOR ANTIBIOTIC-RESISTANT INFECTIONS

Main Article Content

Аннотация:

Bacteriophages, or phages, are viruses found abundantly in the environment and have the ability to infect, replicate within, and ultimately destroy bacteria in a highly specific manner during their lytic phase. Unlike antibiotics, phages have a much narrower host range, making them a promising supplement or even alternative to antibiotic therapy, particularly when combating multiple drug-resistant (MDR) bacterial infections, where antibiotics often fail. The concept of bacteriophage therapy is not new. In fact, bacteriophages were first identified in the early 20th century, with Felix d'Herelle pioneering their therapeutic use after British bacteriologist Frederick W. Twort first described bacterial lysis in 1915. The former Soviet Union consistently used phages to treat infections like gastrointestinal diseases and gas gangrene in soldiers. However, in the Western world, phage therapy fell out of favor following the discovery of penicillin after World War II.

Article Details

Как цитировать:

Saidova , M. . (2024). THE POTENTIAL OF BACTERIOPHAGE THERAPY AS AN ALTERNATIVE TREATMENT FOR ANTIBIOTIC-RESISTANT INFECTIONS. Молодые ученые, 2(30), 40–43. извлечено от https://in-academy.uz/index.php/yo/article/view/38875

Библиографические ссылки:

Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in nature. Bacteriophage. 2011;1:31–45. [DOI] [PMC free article] [PubMed] [Google Scholar]

Romero-Calle D, Guimarães Benevides R, Góes-Neto A, Billington C. Bacteriophages as alternatives to antibiotics in clinical care. Antibiotics. 2019;8(3):138. [DOI] [PMC free article] [PubMed] [Google Scholar]

Twort FW. An investigation on the nature of ultra-microscopic viruses. Lancet. 1915;186(4814):1241–3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Krestovnikova VA. Phage treatment and phage prophylactics and their approval in the works of the Soviet researchers: Springer; 1947. p. 56–65. [Google Scholar]

Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin Infect Dis. 2013;56(10):1445–50. [DOI] [PubMed] [Google Scholar]

Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277–83. [PMC free article] [PubMed] [Google Scholar]

Antimicrobial Resistance Collaborators . Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55. [DOI] [PMC free article] [PubMed] [Google Scholar]

de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med. 2016;13(11):e1002184. [DOI] [PMC free article] [PubMed] [Google Scholar]

Moelling K, Broecker F, Willy C. A wake-up call: we need phage therapy now. Viruses. 2018;10(12):688. [DOI] [PMC free article] [PubMed] [Google Scholar]

Górski A, Borysowski J, Międzybrodzki R. Phage therapy: towards a successful clinical trial. Antibiotics. 2020;9(11):827. [DOI] [PMC free article] [PubMed] [Google Scholar]

Birkle C, Pendlebury DA, Schnell J, Adams J. Web of Science as a data source for research on scientific and scholarly activity. Quan Sci Stud. 2020;1:363–76. [Google Scholar]